Sign up to save your podcasts
Or
Share Pennington, Tulane & ALS Foundation Unite to Tackle ALS Drug Development
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pennington, Tulane & ALS Foundation Unite to Tackle ALS Drug Development
Dr. Jeffrey Keller from the Pennington Biomedical Institute joins the show to highlight a new collaboration with the ALS Foundation and Tulane University. The partnership focuses on developing innovative drug treatments for ALS (Amyotrophic Lateral Sclerosis). Dr. Keller emphasized the importance of combining research expertise and resources to accelerate progress in combating this debilitating disease, aiming to bring hope to patients and families affected by ALS through advanced scientific breakthroughs.
View all episodes
By Guaranty Broadcasting CompanyDr. Jeffrey Keller from the Pennington Biomedical Institute joins the show to highlight a new collaboration with the ALS Foundation and Tulane University. The partnership focuses on developing innovative drug treatments for ALS (Amyotrophic Lateral Sclerosis). Dr. Keller emphasized the importance of combining research expertise and resources to accelerate progress in combating this debilitating disease, aiming to bring hope to patients and families affected by ALS through advanced scientific breakthroughs.